98 related articles for article (PubMed ID: 21782838)
21. Effects of propyphenazone and other non-steroidal anti-inflammatory agents on the synthetic and endogenous androgenic anabolic steroids urinary excretion and/or instrumental detection.
Mazzarino M; Braganò MC; Donati F; de la Torre X; Botrè F
Anal Chim Acta; 2010 Jan; 657(1):60-8. PubMed ID: 19951758
[TBL] [Abstract][Full Text] [Related]
22. Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm.
Goebel C; Howe CJ; Ho KK; Nelson A; Kazlauskas R; Trout GJ
Drug Test Anal; 2009 Nov; 1(11-12):511-7. PubMed ID: 20355166
[TBL] [Abstract][Full Text] [Related]
23. Reporting and managing elevated testosterone/epitestosterone ratios--novel aspects after five years' experience.
Mareck U; Geyer H; Fusshöller G; Schwenke A; Haenelt N; Piper T; Thevis M; Schänzer W
Drug Test Anal; 2010; 2(11-12):637-42. PubMed ID: 21204295
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of sulfate metabolites as markers of intramuscular testosterone administration in Caucasian and Asian populations.
Esquivel A; Alechaga É; Monfort N; Yang S; Xing Y; Moutian W; Ventura R
Drug Test Anal; 2019 Aug; 11(8):1218-1230. PubMed ID: 30932347
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administration.
Kotronoulas A; Gomez-Gómez À; Fabregat A; Segura J; Yang S; Xing Y; Moutian W; Marcos J; Joglar J; Ventura R; Pozo OJ
Drug Test Anal; 2018 May; 10(5):821-831. PubMed ID: 29148228
[TBL] [Abstract][Full Text] [Related]
26. Quantitative confirmation of testosterone and epitestosterone in human urine by LC/Q-ToF mass spectrometry for doping control.
Danaceau JP; Scott Morrison M; Slawson MH
J Mass Spectrom; 2008 Jul; 43(7):993-1000. PubMed ID: 18563866
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part II: Intramuscular administration.
Kotronoulas A; Gomez-Gómez À; Fabregat A; Segura J; Yang S; Xing Y; Moutian W; Marcos J; Joglar J; Ventura R; Pozo OJ
Drug Test Anal; 2018 May; 10(5):849-859. PubMed ID: 29166551
[TBL] [Abstract][Full Text] [Related]
28. Detection and quantification of glucuro- and sulfoconjugated metabolites in human urine following oral administration of xenobiotic 19-norsteroids.
Tseng YL; Sun CY; Kuo FH
Steroids; 2006 Sep; 71(9):817-27. PubMed ID: 16814335
[TBL] [Abstract][Full Text] [Related]
29. Elevated and similar urinary testosterone/epitestosterone ratio in all samples of a competition testing: suspicion of a manipulation.
Robinson N; Castella V; Saudan C; Sottas PE; Schweizer C; Dimo-Simonin N; Mangin P; Saugy M
Forensic Sci Int; 2006 Nov; 163(1-2):148-51. PubMed ID: 16337352
[TBL] [Abstract][Full Text] [Related]
30. Ultra high performance liquid chromatography tandem mass spectrometric detection of glucuronides resistant to enzymatic hydrolysis: Implications to doping control analysis.
Kotronoulas A; Marcos J; Segura J; Ventura R; Joglar J; Pozo OJ
Anal Chim Acta; 2015 Oct; 895():35-44. PubMed ID: 26454457
[TBL] [Abstract][Full Text] [Related]
31. Direct measurement of urinary testosterone and epitestosterone conjugates using high-performance liquid chromatography/tandem mass spectrometry.
Borts DJ; Bowers LD
J Mass Spectrom; 2000 Jan; 35(1):50-61. PubMed ID: 10633234
[TBL] [Abstract][Full Text] [Related]
32. Quantification of testosterone and metabolites released after alkaline treatment in human urine.
Fabregat A; Pozo OJ; Marcos J; Segura J; Ventura R
Drug Test Anal; 2010; 2(11-12):630-6. PubMed ID: 21204294
[TBL] [Abstract][Full Text] [Related]
33. Boldenone, testosterone and 1,4-androstadiene-3,17-dione determination in faeces from horses, untreated and after administration of androsta-1,4-diene-3,17-dione (boldione).
Popot MA; Boyer S; Menaut L; Garcia P; Bonnaire Y; Lesage D
Biomed Chromatogr; 2008 Jun; 22(6):662-70. PubMed ID: 18318019
[TBL] [Abstract][Full Text] [Related]
34. Over-the-counter anabolic steroids 4-androsten-3,17-dione; 4-androsten-3beta,17beta-diol; and 19-nor-4-androsten-3,17-dione: excretion studies in men.
Uralets VP; Gillette PA
J Anal Toxicol; 1999 Sep; 23(5):357-66. PubMed ID: 10488924
[TBL] [Abstract][Full Text] [Related]
35. Population based evaluation of a multi-parametric steroid profiling on administered endogenous steroids in single low dose.
Van Renterghem P; Van Eenoo P; Delbeke FT
Steroids; 2010 Dec; 75(13-14):1047-57. PubMed ID: 20688095
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting urinary excretion of testosterone metabolites conjugated with cysteine.
Fabregat A; Marcos J; Segura J; Ventura R; Pozo OJ
Drug Test Anal; 2016 Jan; 8(1):110-9. PubMed ID: 25917157
[TBL] [Abstract][Full Text] [Related]
37. The effect of oral dehydroepiandrosterone (DHEA) on the urine testosterone/epitestosterone (T/E) ratio in human male volunteers.
Bosy TZ; Moore KA; Poklis A
J Anal Toxicol; 1998 Oct; 22(6):455-9. PubMed ID: 9788520
[TBL] [Abstract][Full Text] [Related]
38. Boldenone, boldione, and milk replacers in the diet of veal calves: the effects of phytosterol content on the urinary excretion of boldenone metabolites.
Gallina G; Ferretti G; Merlanti R; Civitareale C; Capolongo F; Draisci R; Montesissa C
J Agric Food Chem; 2007 Oct; 55(20):8275-83. PubMed ID: 17844992
[TBL] [Abstract][Full Text] [Related]
39. Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport.
Becchi M; Aguilera R; Farizon Y; Flament MM; Casabianca H; James P
Rapid Commun Mass Spectrom; 1994 Apr; 8(4):304-8. PubMed ID: 8199357
[TBL] [Abstract][Full Text] [Related]
40. Optimization of LC method for the determination of testosterone and epitestosterone in urine samples in view of biomedical studies and anti-doping research studies.
Konieczna L; Plenis A; Olędzka I; Kowalski P; Bączek T
Talanta; 2011 Jan; 83(3):804-14. PubMed ID: 21147323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
